1. Home
  2. MC vs KRYS Comparison

MC vs KRYS Comparison

Compare MC & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Moelis & Company

MC

Moelis & Company

HOLD

Current Price

$76.84

Market Cap

5.3B

Sector

Finance

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$289.13

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MC
KRYS
Founded
2007
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
6.3B
IPO Year
2014
2017

Fundamental Metrics

Financial Performance
Metric
MC
KRYS
Price
$76.84
$289.13
Analyst Decision
Buy
Strong Buy
Analyst Count
9
10
Target Price
$74.13
$244.20
AVG Volume (30 Days)
699.6K
294.0K
Earning Date
02-04-2026
02-18-2026
Dividend Yield
3.39%
N/A
EPS Growth
446.16
275.72
EPS
3.17
6.66
Revenue
$1,467,580,000.00
$373,164,000.00
Revenue This Year
$27.41
$36.14
Revenue Next Year
$18.00
$42.38
P/E Ratio
$24.20
$42.93
Revenue Growth
51.19
54.51
52 Week Low
$47.00
$122.80
52 Week High
$82.89
$295.98

Technical Indicators

Market Signals
Indicator
MC
KRYS
Relative Strength Index (RSI) 61.09 70.89
Support Level $74.57 $271.52
Resistance Level $78.22 $295.98
Average True Range (ATR) 2.65 12.15
MACD 0.06 1.56
Stochastic Oscillator 82.93 90.34

Price Performance

Historical Comparison
MC
KRYS

About MC Moelis & Company

Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: